2024-02-20 23:45:21 ET
AbCellera Biologics Inc. (ABCL)
Q4 2023 Results Conference Call
February 20, 2024 5:00 PM ET
Company Participants
Tryn Stimart - Chief Legal & Compliance Officer
Carl Hansen - President, CEO
Andrew Booth - CFO
Conference Call Participants
Robyn Karnauskas - Truist
Andrea Tan - Goldman Sachs
Allison Bratzel - Piper Sandler
Stephen Willey - Stifel
Steven Mah - Cowen
Evan Seigerman - BMO
Presentation
Operator
Good afternoon. Thank you for attending AbCellera Biologics Inc. FY 2023 Earnings Results and business Update Call. My name is Matt, and I will be your moderator for today's call. [Operator Instructions]
I would now like to pass the conference call over to our host Tryn Stimart, Chief Legal and Compliance Officer with AbCellera. Tryn, please go ahead.
Tryn Stimart
Thank you. Good morning, good afternoon, good evening to everyone listening around the world. Thank you for joining us for AbCellera's full year 2023 earnings call. I'm Tryn Stimart, AbCellera's Chief Legal and Compliance Officer. Joining me on today's call are Dr. Carl Hansen, AbCellera's President and Chief Executive Officer; and Andrew Booth, AbCellera's Chief Financial Officer.
During this call, we anticipate making projections and forward-looking statements based on our current expectations and pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Our actual results could differ materially due to several factors as set forth in our latest form 10-K and subsequent forms 10-Q and 8-K filed with the Securities and Exchange Commission.
AbCellera does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Our presentation today, including our earnings press release issued earlier today and our SEC filings are available on our Investor Relations website. The information we provide about our pipeline is for the benefit of the investment community and is not intended to be promotional. As we transition to our prepared remarks, please note that all dollars referred to during the call are in U.S. dollars. After our prepared remarks, we will open the lines for questions and answers....
Read the full article on Seeking Alpha
For further details see:
AbCellera Biologics Inc. (ABCL) Q4 2023 Earnings Call Transcript